文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

早产儿视网膜病变抗血管内皮生长因子治疗失败的特征与结局

CLINICAL FEATURES AND OUTCOMES OF INFANTS WITH RETINOPATHY OF PREMATURITY WHO FAIL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
PubMed 文献 · Retina · 2021-01-01

该回顾性病例系列描述了2011至2019年间单中心以抗血管内皮生长因子(VEGF)作为早产儿视网膜病变初始治疗的211眼(112例)及另6眼(3例)转诊失败病例。本中心初始治疗眼失败率为11%(17眼),失败表现以复发性plus(58%)和复发性3期(54%)最常见,部分失败发生于矫正胎龄50周后;多数失败眼经激光、重复注射或玻璃体切除等处理后解剖结局良好。

要点

  • 本中心抗VEGF初始治疗失败率为11%(17/211眼)。
  • 失败最常见表现为复发性plus(58%)和复发性3期(54%)。
  • 部分失败发生于矫正胎龄50周后(3/23眼,13%),需延长随访。

核心结论

  • 抗VEGF治疗失败最常见的表现为复发性plus和复发性3期。
  • 本中心初始治疗失败率为11.0%,相当比例失败发生于矫正胎龄50周后。
  • 多数失败眼经补救治疗后解剖结局良好,超过半数存在注视行为。

研究设计与样本

  • 单中心回顾性病例系列,纳入2011至2019年以抗VEGF作为ROP初始治疗的211眼(112例)。
  • 另纳入转诊至本中心管理的抗VEGF治疗失败眼6眼(3例)。
  • 共管理23眼治疗失败病例,其中18眼有≥6个月随访。

主要发现

  • 211眼初始治疗中17眼(11%)失败。
  • 23眼失败病例中,复发性plus 14眼(58%)、复发性3期13眼(54%)、视网膜脱离5眼(21%)。
  • 3眼(13%)失败发生于矫正胎龄50周后。
  • 失败处理方式包括激光(13眼)、重复注射(4眼)、玻璃体切除(2眼)或联合治疗(4眼)。
  • 18眼随访≥6个月中,17眼视网膜完全复位,10眼存在注视行为。

临床怎么用

  • 抗VEGF初始治疗后需警惕复发性plus和复发性3期,并延长随访至矫正胎龄50周后。
  • 治疗失败可根据表现选择激光、重复注射、玻璃体切除或联合治疗。

局限性

  • 回顾性单中心设计,样本量有限且部分失败眼随访不足6个月。
  • 转诊失败病例来自外院,初始治疗信息可能不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe characteristics and outcomes of patients with retinopathy of prematurity who failed intravitreal antivascular endothelial growth factor. METHODS: A retrospective case series of 211 eyes (112 patients) treated with antivascular endothelial growth factor as initial therapy for retinopathy of prematurity at a single academic institution between 2011 and 2019 and an additional 6 eyes (3 patients) referred to us for management of failed antivascular endothelial growth factor. RESULTS: Among the 211 eyes receiving initial treatment at our institution, 17 eyes (11%) failed. Of the 23 total eyes managed by us for failure, 3 eyes (13%) failed after 50-week postmenstrual age. Failure manifested as recurrent plus in 14 eyes (58%), recurrent Stage 3 in 13 eyes (54%) and retinal detachment in 5 eyes (21%). Treatment failures were managed with laser (13 eyes), repeat injection (4 eyes), vitrectomy (2 eyes), or a combination of modalities (4 eyes). Follow-up of ≥6 months was available for 18 of the 23 eyes. The retina was fully attached in 17 eyes, and fixation behavior was present in 10 eyes. CONCLUSION: The most common manifestations of treatment failure were recurrent plus and Stage 3. The failure rate at our institution was 11.0%. A significant proportion of failures occurred after 50-week postmenstrual age. Most failed eyes had favorable anatomical outcomes and over half demonstrated fixation behavior.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Xu LT, Levine DA, Hutchinson AK, et al. CLINICAL FEATURES AND OUTCOMES OF INFANTS WITH RETINOPATHY OF PREMATURITY WHO FAIL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Retina. 2021. PMID: 34190725. doi:10.1097/IAE.0000000000003249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。